LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$35.87
-0.41 (-1.13%)
▼
5d:
+9.96%
30d:
+25.11%
90d:
+91.31%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: LEGN is 7.7% above its trading range ($33.31). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: LEGN is 7.7% above its trading range ($33.31). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$64.99
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$40.36
11.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $35.87, which is considered extended relative to its 30-day fair value range of $26.61 to $33.31. From a valuation perspective, the stock is trading at a discount (Forward PE: 26.9) compared to its historical average (38.9). Remarkably, the market is currently pricing in an annual earnings decline of 11.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a strong uptrend. Immediate support is located at $24.81, while resistance sits at $37.50.
Market Sentiment: LEGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $57.59 (+60.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEGN is in a strong uptrend. Immediate support is located at $24.81, while resistance sits at $37.50.
Market Sentiment: LEGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $57.59 (+60.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$26.61 -
$33.31
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+7.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.6% below Wall St target ($57.59)
Trading Range Analysis
30-Day Trading Range
$26.61 -
$33.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$24.81
Resistance Level
$37.50
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.87
Wall Street Target
$57.59
(+60.6%)
Revenue Growth (YoY)
56.5%
Profit Margin
-22.0%
Valuation Discount vs History
-11.6% cheaper
PE vs Historical
26.9 vs 38.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.6%
(market-implied from PE analysis)
1-Year Target
$32.28
(-10%)
2-Year Target
$29.05
(-19%)
3-Year Target
$26.15
(-27%)
3-Yr Target (if PE normalizes)
(PE: 27→39)
$37.86
(+6%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.9, Growth: 376.8%)
$121.06
(+238%)
Base:
(SPY PE: 21.9, Growth: 376.8%)
$98.76
(+175%)
Bear:
(PE: 18.6, Growth: 376.8%)
$83.95
(+134%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 26.9 to 38.9
Stabilization Target:
$51.93
(+44.8%)
PE Expansion Potential:
+44.8%
Share & Embed Analysis
Last updated: June 14, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1029 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 66 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 48 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 51 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 52 HOLD |
